Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1910 in Healthy Participants
Clinical trial NCT05307978 · COMPLETED
Trial details
- NCT number
- NCT05307978
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-12
- Primary completion
- 2023-02-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.